Chloramphenicol | Ceftriaxone | |||
---|---|---|---|---|
No. | No. with adverse outcome (%) (died/severe sequelae) | No. | No. with adverse outcome (%) (died/severe sequelae) | |
Meningitis (all cases) | 15 0 | 48 (32%) (31/17) | 196 | 53 (27.0%) (29/23) |
Hib meningitis (culture or antigen positive) | 45 | 12 (26.7%) (4/8) | 65 | 12 (18.5%) (5/7) |
Hib meningitis (culture positive) | 36 | 10 (27.8%) (3/7) | 54 | 10 (18.5%) (4/6) |
Chloramphenicol sensitive Hib meningitis | 29 | 5 (17.2%) (0/5) | 43 | 9 (20.9%) (3/6) |
Chloramphenicol resistant Hib meningitis | 7 | 5 (71.4%) (3/2) | 11 | 1 (9.1%) (1/0) |